• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷苯妥英保质期的延长:通过与(SBE)7m-β-环糊精络合使降解产物苯妥英增溶。

Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.

作者信息

Narisawa S, Stella V J

机构信息

Department of Pharmaceutical Chemistry and Higuchi Biosciences Center for Drug Delivery Research, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA.

出版信息

J Pharm Sci. 1998 Aug;87(8):926-30. doi: 10.1021/js980041h.

DOI:10.1021/js980041h
PMID:9687335
Abstract

Fosphenytoin, a water-soluble prodrug of phenytoin, degrades primarily to phenytoin at pH values <8 during long term storage; phenytoin readily precipitates when formed from fosphenytoin due to its limited aqueous solubility. The objective of this study was to develop stable formulations of fosphenytoin in the pH range of 7.4-8. 0 by inhibiting the phenytoin precipitation through complexation with a parenterally safe cyclodextrin, (SBE)7m-beta-CD. Phase solubility studies at 25 degreesC revealed that phenytoin could be effectively solubilized by (SBE)7m-beta-CD both in the presence and absence of 80.6 mg/mL fosphenytoin (as its dihydrate). The binding constants for the phenytoin/cyclodextrin complex were found to be 1073 and 792 M-1 at pH 7.4 and pH 8.0, respectively. Because of the competitive inclusion between fosphenytoin and phenytoin with (SBE)7m-beta-CD, the extent of solubilization of phenytoin was lower, as expected, in the presence of fosphenytoin than in the absence of fosphenytoin, even though the binding constants for the fosphenytoin/cyclodextrin complex were relatively small (41-45 M-1). Initial rates were used to follow the production of phenytoin from fosphenytoin. Zero-order kinetics were observed under all conditions investigated. Phenytoin production rates were followed at 25, 37, and 50 degreesC in the presence of 0.03 or 0.06 M (SBE)7m-beta-CD. It was projected from the solubility of phenytoin and the kinetic information that fosphenytoin shelf lives as high as nine years at 25 degreesC and pH 7.4 in the presence of 60 mM of (SBE)7m-beta-CD might be possible while longer shelf lives might be possible at pH 8.

摘要

磷苯妥英是苯妥英的水溶性前体药物,在长期储存期间,当pH值小于8时主要降解为苯妥英;由于苯妥英的水溶性有限,其由磷苯妥英形成时很容易沉淀。本研究的目的是通过与肠外安全的环糊精(SBE)7m-β-CD络合来抑制苯妥英沉淀,从而开发出pH值范围在7.4至8.0之间的磷苯妥英稳定制剂。25℃下的相溶解度研究表明,无论有无80.6mg/mL磷苯妥英(其二水合物形式),苯妥英都能被(SBE)7m-β-CD有效增溶。发现苯妥英/环糊精络合物在pH7.4和pH8.0时的结合常数分别为1073和792M-1。由于磷苯妥英和苯妥英与(SBE)7m-β-CD之间存在竞争性包合,正如预期的那样,即使磷苯妥英/环糊精络合物的结合常数相对较小(41 - 45M-1),在存在磷苯妥英的情况下,苯妥英的增溶程度仍低于不存在磷苯妥英时。采用初始速率来跟踪磷苯妥英生成苯妥英的过程。在所研究的所有条件下均观察到零级动力学。在存在0.03或0.06M(SBE)7m-β-CD的情况下,在25、37和50℃下跟踪苯妥英的生成速率。根据苯妥英的溶解度和动力学信息推测,在存在60mM(SBE)7m-β-CD的情况下,磷苯妥英在25℃和pH7.4时的货架期可能高达9年,而在pH8时可能有更长的货架期。

相似文献

1
Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.磷苯妥英保质期的延长:通过与(SBE)7m-β-环糊精络合使降解产物苯妥英增溶。
J Pharm Sci. 1998 Aug;87(8):926-30. doi: 10.1021/js980041h.
2
Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.环糊精催化的螺内酯脱乙酰化反应取决于pH值和环糊精。
J Pharm Sci. 2000 Feb;89(2):241-9. doi: 10.1002/(SICI)1520-6017(200002)89:2<241::AID-JPS11>3.0.CO;2-0.
3
Degradation of NSC-281612 (4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability.实验性抗肿瘤药物NSC-281612(4-[双[2-[(甲基磺酰基)氧基]乙基]氨基]-2-甲基苯甲醛)的降解:pH值、溶剂组成、(SBE)7m-β-环糊精和羟丙基-β-环糊精对稳定性的影响
J Pharm Sci. 2004 Mar;93(3):532-9. doi: 10.1002/jps.10571.
4
Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.环糊精电荷对中性和带电底物络合作用的影响:(SBE)7M-β-环糊精与羟丙基-β-环糊精的比较
Pharm Res. 2001 May;18(5):667-73. doi: 10.1023/a:1011041628797.
5
Comparative effects of (SBE)7m-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.(SBE)7m-β-环糊精和羟丙基-β-环糊精对两种抗肿瘤药物美法仑和卡莫司汀稳定性的比较影响。
J Pharm Sci. 2000 Feb;89(2):275-87. doi: 10.1002/(SICI)1520-6017(200002)89:2<275::AID-JPS15>3.0.CO;2-C.
6
Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.使用(SBE)7m-β-环糊精作为增溶剂和渗透泵剂,从渗透泵片中释放睾酮。
J Control Release. 1999 Mar 8;58(1):29-38. doi: 10.1016/s0168-3659(98)00142-4.
7
New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.利用(SBE)(7m)-β-环糊精或羟丙基-β-环糊精的新型注射用美法仑制剂。
Int J Pharm. 1999 Nov 5;189(2):227-34. doi: 10.1016/s0378-5173(99)00255-0.
8
Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.使用(SBE)(7m)-β-环糊精作为增溶剂,从羟丙基甲基纤维素骨架片中对模型难溶性药物泼尼松龙进行可控且完全的释放。
J Pharm Sci. 2001 Jul;90(7):807-16. doi: 10.1002/jps.1034.
9
Combined effect of SLS and (SBE)(7M)-beta-CD on the solubilization of NSC-639829.月桂醇硫酸酯钠与七聚麦芽糖-β-环糊精对NSC-639829的增溶联合作用
Int J Pharm. 2004 Jan 9;269(1):141-8. doi: 10.1016/j.ijpharm.2003.09.001.
10
Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.环糊精:溴己新液体制剂和半固体制剂的高效生物相容性增溶辅料。
Int J Pharm. 2012 Jan 17;422(1-2):349-55. doi: 10.1016/j.ijpharm.2011.10.023. Epub 2011 Oct 17.

引用本文的文献

1
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics.环糊精:提升现代治疗药物的递送、溶解度及生物利用度。
Pharmaceutics. 2025 Feb 22;17(3):288. doi: 10.3390/pharmaceutics17030288.